These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 14231514)

  • 1. [FIELD TRIAL OF ORAL POLIO VACCINATION].
    PEREZGALLARDO F; VEGAVILLALONGA J; PEREZMEL J; LOPEZVILLALBA L; NAJERAMORRONDO R
    Rev Sanid Hig Publica (Madr); 1964; 38():443-501. PubMed ID: 14231514
    [No Abstract]   [Full Text] [Related]  

  • 2. [VIROLOGICAL STUDY DONE IN RELATION TO THE FIELD OF ORAL SABIN POLIO VACCINE].
    PEREZGALLARDO F; VALENCIANOCLAVEL L; GABRIELYGALAN J
    Rev Sanid Hig Publica (Madr); 1964; 38():502-10. PubMed ID: 14230442
    [No Abstract]   [Full Text] [Related]  

  • 3. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The polio endgame.
    Minor P
    Hum Vaccin Immunother; 2014; 10(7):2106-8. PubMed ID: 25608050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. POLIO IMMUNIZATION.
    CROIELL LL; RICHARDSON FM
    Med Sci; 1964 Feb; 15():67-81. PubMed ID: 14118942
    [No Abstract]   [Full Text] [Related]  

  • 8. POLIO VACCINE LIVE ORAL (SABIN) (ADMINISTRATION IN BOMBAY TO SMALL GROUPS).
    MEHERHOMJI KM; RAO VK; DAVE KH; GHARPURE PV; JHALA HI
    Indian J Pathol Bacteriol; 1964 Apr; 55():74-85. PubMed ID: 14157679
    [No Abstract]   [Full Text] [Related]  

  • 9. ORAL POLIO VACCINATION PROGRAM IN HILLSBOROUGH COUNTY USING A SABIN TRIVALENT VACCINE.
    NEILL JS; BURKE SK; BOND JO; SCHNEIDER NJ
    South Med J; 1963 Nov; 56():1239-44. PubMed ID: 14078371
    [No Abstract]   [Full Text] [Related]  

  • 10. An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication.
    Minor PD
    Methods Mol Biol; 2016; 1387():1-10. PubMed ID: 26983727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE IMMUNIZING EFFECT OF A TWO-DOSE TRIVALENT ORAL POLIO VACCINE.
    CLAYTON LB; FLIPSE ME; HOFFERT WR; CROSSLEY MI
    Curr Ther Res Clin Exp; 1965 Jan; 7():1-6. PubMed ID: 14246364
    [No Abstract]   [Full Text] [Related]  

  • 12. [Circulation of the poliovirus in endemic zones with children vaccinated by the oral polio vaccine].
    Gouandjika I; Rakoto Andrianarivelo M; Akoua-Koffi C; Zeller H; Ehouman A; Morvan JM
    Bull Soc Pathol Exot; 2000 Jul; 93(3):198-201. PubMed ID: 11030057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating cessation of the type 2 oral polio vaccine by modeling pre- and post-cessation detection rates.
    Kroiss SJ; Famulare M; Lyons H; McCarthy KA; Mercer LD; Chabot-Couture G
    Vaccine; 2017 Oct; 35(42):5674-5681. PubMed ID: 28890193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral polio vaccine.
    TAUBENHAUS LJ; FRECKLETON FR
    Med Times; 1962 Apr; 90():361-4. PubMed ID: 13919831
    [No Abstract]   [Full Text] [Related]  

  • 15. [End phase challenges of poliomyelitis eradication programme realization].
    Jarzabek Z
    Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intense campaign for vaccination with the oral polio vaccine: what are the repercussions on the enterovirus world?].
    Delpeyroux F; Guillot S; Szendröi A; Balanant J; Caro V; Cuervo N; Chevaliez S; Dahourou G; Crainic R
    Bull Soc Pathol Exot; 2000 Jul; 93(3):193-7. PubMed ID: 11030056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria.
    Famulare M; Chang S; Iber J; Zhao K; Adeniji JA; Bukbuk D; Baba M; Behrend M; Burns CC; Oberste MS
    J Virol; 2016 Jan; 90(1):317-31. PubMed ID: 26468545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CONSIDERATIONS ON REACTIVE MANIFESTATIONS AFTER SABIN ANTI-POLIO VACCINATION].
    MORRONE G
    Pediatria (Napoli); 1964 Dec; 72():1363-9. PubMed ID: 14255392
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged poliovirus excretion in an immunodeficient person with vaccine-associated paralytic poliomyelitis.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jul; 46(28):641-3. PubMed ID: 9233551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral poliovirus vaccination. Retrospect and perspectives].
    JOPPICH G
    Med Welt; 1962 Dec; 50():2647-50. PubMed ID: 13964869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.